SKI Market

A+| A| A-|

Indian Indices

Sensex

77,550.25 918.60
( 1.20%)

Global Indices

Nasdaq

47,930.49 -276.32
(-0.57%)

Dow Jones

6,837.38 -8.28
(-0.12%)

Hang Seng

56,916.27 1,020.95
(1.83%)

Nikkei 225

10,596.33 -7.15
(-0.07%)

Forex

USD-INR

92.50 0.06
(0.07%)

EUR-INR

108.05 0.09
(0.08%)

GBP-INR

124.08 0.03
(0.03%)

JPY-INR

0.58 0.00
(-0.25%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

17.34

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

253

57.87

EPS(TTM)

Face Value()

Div & Yield %

0.15

Back

radhagobind commercial ltd

Oxygenta Pharmaceutical reports standalone net loss of Rs 4.84 crore in the December 2025 quarter

Feb 05,2026

Net Loss of Oxygenta Pharmaceutical reported to Rs 4.84 crore in the quarter ended December 2025 as against net loss of Rs 3.93 crore during the previous quarter ended December 2024. Sales rose 2.17% to Rs 33.93 crore in the quarter ended December 2025 as against Rs 33.21 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	33.93	33.21	2
OPM %	-12.00	-13.10	-
PBDT	-5.46	-4.25	-28
PBT	-6.32	-4.96	-27
NP	-4.84	-3.93	-23

77,550.25 918.60 ( 1.20%)

47,930.49 -276.32 (-0.57%)

6,837.38 -8.28 (-0.12%)

56,916.27 1,020.95 (1.83%)

10,596.33 -7.15 (-0.07%)

92.50 0.06 (0.07%)

108.05 0.09 (0.08%)

124.08 0.03 (0.03%)

0.58 0.00 (-0.25%)